Could This Listing Close the Valuation Gap With Micron?

The article argues SK Hynix’s potential Nasdaq access could narrow its long-standing ~35% valuation premium vs Micron (driven more by trading/plumbing than fundamentals), providing a modest, durable tailwind. However, it warns that AI/HBM memory sentiment is cyclical and could fade as memory capacity threatens oversupply by 2027–2028, which could lead multiples to compress even with the new listing. Net: structural benefits help, but re-rating depends on AI-memory demand staying strong longer than history suggests.

Analysis

The listing is primarily a liquidity and ownership event, not a business-model event. The first-order beneficiary is SKHY because broader U.S. access can compress the Korea discount and lower the equity-risk premium; the second-order loser is MU on a relative basis if investors decide they can own the higher-quality HBM franchise without paying the historical access penalty. TSM is a softer beneficiary as the market’s willingness to pay up for U.S.-accessible Asian semis improves, but that effect is more precedent than direct flow.

The key distinction is timing. Over days to weeks, the trade is flow-driven and can reprice quickly if U.S. institutions actually show up; over 1-3 months, the next HBM/DRAM print will decide whether the rerating has earnings support or is just a one-off listing pop. If lead times normalize or hyperscaler orders flatten, both SKHY and MU can lose 15-30% from peak multiple levels even if reported fundamentals remain decent, because the market will switch from scarcity pricing to peak-cycle pricing.

Consensus may be overstating what plumbing can fix. SKHY was already the quality leader, so the listing only matters if it materially expands float demand and indexability; absent that, the valuation gap is mostly a narrative trade. The contrarian risk is that investors treat Nasdaq access as structural validation just as the memory cycle turns, which would leave the stock with better visibility but worse earnings duration.

Key Decisions for Investors

• Modest long SKHY / short MU pair for 1-3 months to play valuation-gap closure; target 5-10% relative outperformance, cut if SKHY fails to outperform after the first U.S.-trading/liquidity window or if HBM pricing rolls over.
• Use strength to reduce outright beta in MU and NVDA rather than chase the rerating; the listing can lift SKHY’s multiple, but it does not protect the whole AI-memory complex if the market starts pricing peak cycle.
• If you want AI semis exposure with less memory-cycle risk, prefer long TSM vs short MU over a 6-12 month horizon; TSM has better duration if the market shifts from scarcity to normalization.
• Set a watch trigger on U.S. turnover and foreign ownership for SKHY over the next quarter: if volume and institutional participation do not expand meaningfully, treat the rerating thesis as mostly failed and exit the relative-value trade.